What Sage Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Barrett Elizabeth A. | Director | Jul 31 | Tender Offer · U | −3,000 | — | — | 0 |
| Golumbeski George | Director | Jul 31 | Tender Offer · U | −8,000 | — | — | 0 |
| Frates James M | Director | Jul 31 | Tender Offer · U | −2,845 | — | — | 0 |
| Greene Barry E | President and CEO | Jul 31 | Disposition to Issuer · D | −53,229 | — | — | 0 |
| Greene Barry E | President and CEO | Jul 31 | Tender Offer · U | −46,940 | — | — | 0 |
| Shiferman Gregory L. | See Remarks | Jul 31 | Disposition to Issuer · D | −23,735 | — | — | 0 |
| Shiferman Gregory L. | See Remarks | Jul 31 | Tender Offer · U | −7,215 | — | — | 0 |
| Benecchi Christopher | Chief Operating Officer | Jul 31 | Disposition to Issuer · D | −36,375 | — | — | 0 |
| Benecchi Christopher | Chief Operating Officer | Jul 31 | Disposition to Issuer · D | −28,053 | — | — | 0 |
| Quirk Michael C. | See Remarks | Jul 31 | Disposition to Issuer · D | −7,962 | — | — | 0 |
| Quirk Michael C. | See Remarks | Jul 31 | Disposition to Issuer · D | −24,999 | — | — | 0 |
| Shiferman Gregory L. | See Remarks | Jun 24 | Withheld — tax / exercise cost · F | −79 | $9.22 | −$728 | 30,950 |
| Quirk Michael C. | See Remarks | Jun 24 | Withheld — tax / exercise cost · F | −113 | $9.22 | −$1.04K | 30,461 |
| Greene Barry E | President and CEO | Apr 10 | Withheld — tax / exercise cost · F | −4,862 | $6.91 | −$33.6K | 100,169 |
| Greene Barry E | President and CEO | Apr 10 | Grant / award · A | +19,964 | — | — | 105,031 |
| Shiferman Gregory L. | See Remarks | Apr 10 | Withheld — tax / exercise cost · F | −176 | $6.91 | −$1.22K | 31,029 |
| Shiferman Gregory L. | See Remarks | Apr 10 | Grant / award · A | +525 | — | — | 31,205 |
| Quirk Michael C. | See Remarks | Apr 10 | Withheld — tax / exercise cost · F | −424 | $6.91 | −$2.93K | 30,574 |
| Quirk Michael C. | See Remarks | Apr 10 | Grant / award · A | +1,269 | — | — | 30,998 |
| Quirk Michael C. | See Remarks | Apr 10 | Withheld — tax / exercise cost · F | −312 | $6.91 | −$2.16K | 29,729 |
Loading...
